Showing results (321-330 of 525) with videos related to

Sort By:
Pageof 53
Thrombosis Research|June 1, 1997
Effect of isradipine on in-vivo platelet functionJ O'Grady, H Kritz, P Schmid, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|March 1, 1994
Isradipine inhibits mitotic and proliferative activity in the arterial wallP Fitscha, F Rauscha, J O'Grady, et al.
Nuklearmedizin. Nuclear Medicine|February 1, 1989
[Loss of high-affinity prostacyclin binding sites in patients with Basedow's disease]I Virgolini, K Weiss, M Hermann, et al.
Wiener Klinische Wochenschrift|January 1, 1991
[Risk factors of atherosclerosis: results of screening in Southern Austria]K Weiss, R Katzenschlager, H Egert, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 1, 1989
Effects of taprostene, a chemically stable prostacyclin analogue, in patients with ischaemic peripheral vascular disease: a placebo controlled double-blind trialI Virgolini, P Fitscha, J O'Grady, et al.
Thrombosis Research|January 15, 1996
Apolipoprotein A and biological half-life of prostaglandin I2 in HIV-1 infectionC Pirich, Y Efthimiou, J O'Grady, et al.
Thrombosis Research|August 29, 1998
Accumulation of platelets as a key mechanism of human erectionM Rodrigues, J O'Grady, W Stackl, et al.
Wiener Klinische Wochenschrift|July 16, 1976
[LDH isoenzymes and gastrin in achlorhydri (author's transl)]S Mohamedi, E Penner, H Brunner, et al.
Wiener Klinische Wochenschrift|December 8, 1989
[In vivo flow of autologous radioactively labeled low-density lipoproteins (LDL) in human blood vessels]I Virgolini, P Angelberger, G Lupattelli, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 1, 1992
The diminished extracellular matrix production induced by isradipine, a calcium channel blocker, is completely abolished by cyclooxygenase inhibitionP Fitscha, A Keiler, F Rauscha, et al.
Pageof 53